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Abstract
Background: Severe mental illness (SMI), comprising schizophrenia, bipolar disorder and major depression, is
associated with higher myocardial infarction (MI) mortality but lower coronary revascularisation rates. Previous
studies have largely focused on schizophrenia, with limited information on bipolar disorder and major depression,
long-term mortality or the effects of either sociodemographic factors or year of MI. We investigated the associations
between SMI and MI prognosis and how these differed by age at MI, sex and year of MI.
Methods: We conducted a national retrospective cohort study, including adults with a hospitalised MI in Scotland
between 1991 and 2014. We ascertained previous history of schizophrenia, bipolar disorder and major depression
from psychiatric and general hospital admission records. We used logistic regression to obtain odds ratios adjusted
for sociodemographic factors for 30-day, 1-year and 5-year mortality, comparing people with each SMI to a
comparison group without a prior hospital record for any mental health condition. We used Cox regression to
analyse coronary revascularisation within 30 days, risk of further MI and further vascular events (MI or stroke). We
investigated associations for interaction with age at MI, sex and year of MI.
Results: Among 235,310 people with MI, 923 (0.4%) had schizophrenia, 642 (0.3%) had bipolar disorder and 6239
(2.7%) had major depression. SMI was associated with higher 30-day, 1-year and 5-year mortality and risk of further
MI and stroke. Thirty-day mortality was higher for schizophrenia (OR 1.95, 95% CI 1.64–2.30), bipolar disorder (OR
1.53, 95% CI 1.26–1.86) and major depression (OR 1.31, 95% CI 1.23–1.40). Odds ratios for 1-year and 5-year mortality
were larger for all three conditions. Revascularisation rates were lower in schizophrenia (HR 0.57, 95% CI 0.48–0.67),
bipolar disorder (HR 0.69, 95% CI 0.56–0.85) and major depression (HR 0.78, 95% CI 0.73–0.83). Mortality and
revascularisation disparities persisted from 1991 to 2014, with absolute mortality disparities more apparent for MIs
that occurred around 70 years of age, the overall mean age of MI. Women with major depression had a greater
reduction in revascularisation than men with major depression.
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Conclusions: There are sustained SMI disparities in MI intervention and prognosis. There is an urgent need to
understand and tackle the reasons for these disparities.
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Background
Cardiovascular disease (CVD) is a major contributor to
the marked premature mortality in people with severe
mental illness (SMI), including schizophrenia, bipolar
disorder and major depression [1–5]. There has been
considerable research on the impact of SMI on CVD oc-
currence, but far less on the effect on CVD outcomes.
Over the past 20 years, accumulating evidence suggests
that people with SMI have poorer outcomes following a
myocardial infarction (MI) [6–8] and are less likely to
receive coronary revascularisation than those without
mental illness [7, 9–12]. However, most studies have ex-
amined the effect of schizophrenia on MI outcomes [8,
11], with far less investigation of the effect of prior bipo-
lar disorder [6, 7, 9, 13] or major depression [7, 10]. Ef-
fects of SMI on longer-term mortality (beyond 1-year
post-MI) have rarely been studied [14], no study (to our
knowledge) has specifically assessed further MI and
there are limited data on whether associations differ by
age at MI and sex. The relative risk of mortality in youn-
ger people with schizophrenia may be lower than in
older people [6], whilst women with SMI may be treated
more conservatively than men with the same illness [7].
It is unclear whether disparities in mortality and revas-
cularisation are changing over time. The MI mortality
gap for schizophrenia compared to the general popula-
tion may have widened between 1995 and 2015 in
Denmark [14], whilst mental health disparities in revas-
cularisation rates do not appear to be narrowing in the
USA [9, 10]. To our knowledge, no study has reported
trends in coronary revascularisation following MI by
year of MI and SMI status in a universal healthcare
setting.
We therefore conducted a retrospective cohort
study to investigate the effect of a previous diagnosis
of schizophrenia, bipolar disorder and major depres-
sion on risks of mortality, further MI and other
vascular events, and rates of revascularisation follow-
ing hospital admission for MI, by year of MI, age at
MI and sex. We analysed SMI conditions separately
to achieve greater epidemiological insight across these
disorders. Whilst they share some commonalities in
the pattern of association with physical disease, it
may be inappropriate to assume they are homoge-
neous with respect to patterns of physical disease out-
comes and receipt of clinical care.
Methods
This study is reported in accordance with the Standard
Reporting of Observational Studies in Epidemiology
(STROBE) [15] and Reporting of Studies Conducted
using Observational Routinely Collected Health Data
(RECORD) [16] statements.
Study population
We identified all adults aged 18 and over with a diagno-
sis of MI recorded in the Scottish Morbidity Record
General/Acute Inpatient and Day Case dataset (SMR01,
see https://www.ndc.scot.nhs.uk/Data-Dictionary/SMR-
Datasets/SMR01-General-Acute-Inpatient-and-Day-
Case/) between 1 January 1991 and 31 December 2014.
SMR01 includes details of all acute hospital admis-
sions in Scotland from 1980 onwards and information
on clinical procedures/interventions coded using the
fourth revision of the OPCS Classification of Inter-
ventions and Procedures (OPCS-4). We identified in-
cident MIs using the ninth and tenth revisions of the
International Classification of Diseases (ICD9 410 and
ICD10 I21 and I22), where codes were included in a
primary or secondary diagnosis field. We defined inci-
dent events as MIs that occurred between 1 January
1991 and 31 December 2014, where no previous ad-
missions to hospital for MI had been recorded during
the preceding 10 years.
Definition and ascertainment of SMI
We determined the history of a mental health condition
from the Scottish Mental Health Inpatient and Day Case
(SMR04) dataset (which records psychiatric hospital ad-
missions from 1981 onward) and the SMR01 dataset.
We identified mental health conditions from primary or
secondary diagnosis fields of admissions that occurred
after the individual’s 18th birthday and before their inci-
dent MI (Additional file 1: Table S1) [17, 18]. We cate-
gorised people into three mutually exclusive SMI
groups. Where individuals had a record of more than
one diagnosis, we used a severity hierarchy, with schizo-
phrenia considered the most severe, followed by bipolar
disorder and major depression. We compared MI out-
comes in people with a history of each of these three
disorders to those with no prior hospital record for any
mental health condition.
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Outcomes
Primary outcomes were 30-day and 1-year mortality
and coronary revascularisation. Secondary outcomes
included 5-year mortality, mortality over the entire
follow-up period, time to further MI and time to fur-
ther vascular event (fatal or non-fatal MI or stroke).
We identified deaths up to 31 December 2018 from
Scottish death records which include date and cause
of death, as recorded on the death certificate. The
analysis of 5-year mortality includes a smaller cohort
of MI admissions up to 2013 so that all individuals
potentially have at least 5 years of follow-up. For
mortality over the entire follow-up period, time to
death was calculated from the date of the incident MI
to the date of death, with follow-up to the end of
2018. We identified the following coronary revascular-
isation procedures from OPCS-4 codes recorded in
SMR01 (Additional file 1: Table S2) [19]: percutan-
eous transluminal coronary angioplasty (PTCA), per-
cutaneous coronary intervention (PCI) and coronary
artery bypass graft (CABG). We investigated coronary
revascularisation within 30 days in line with the time
frame used in previous studies of revascularisation
following MI. Time to revascularisation was calculated
from the date of the incident MI to the date of the
first subsequent revascularisation procedure, regard-
less of whether the individual experienced another
MI. We identified further events (occurring more
than 30 days after the index MI) from SMR01 and
death records based on conditions recorded in pri-
mary or secondary fields. We identified further MI
using the same ICD-9 and ICD-10 codes as for the
index MI and stroke using ICD-9 codes 430, 431, 434
and 436 and ICD-10 codes I60, I61, I63 and I64.
Time to further MI and time to further vascular
event were each calculated from the date of the inci-
dent MI to the date of the next MI or vascular event,
as appropriate, regardless of whether revascularisation
was received.
Sociodemographic and clinical covariates
Area-based deprivation, urbanicity and NHS health
board (with Scotland divided into 14 regional areas
for the purposes of healthcare delivery) were defined
based on each person’s place of residence at the time
of MI. Area-based deprivation was measured by the
Carstairs Index in line with recommendations for the
analysis of deprivation in Scotland where the time
frame starts prior to 1996 [20]. The Carstairs Index is
based on four census variables (car ownership, male
unemployment, household overcrowding and low oc-
cupational social class), calculated at the postcode
sector level and divided into quintiles based on the
entire Scottish population (Additional file 1: Text S1)
[20–22]. Urbanicity was classified according to the
Scottish Government sixfold urban rural indicator
[23]. We ascertained history of alcohol use disorder
based on all hospital records before the date of first
MI and defined it using ICD codes for mental and
behavioural disorders due to alcohol use and physical
health conditions caused by alcohol use disorder (as
listed in Additional file 1: Table S3). For each MI, we
used ICD codes to identify diagnoses of diabetes,
chronic obstructive pulmonary disease (COPD) and
heart failure from the hospital discharge record for
the index MI (Additional file 1: Table S4).
Statistical analyses
We used direct standardisation to calculate sex-specific
age-standardised rates for the three primary outcomes,
by age at MI and year of MI group. We used only four
age groups (< 60, 60–69, 70–79 and ≥ 80 years) and four
year groups of equal duration to ensure that there were
sufficient numbers within each group for the standard-
isation. We derived sex-specific age distributions for the
standard population from the distributions observed in
the period 2003–2008.
We used logistic regression to model 30-day, 1-year
and 5-year mortality, and Cox proportional hazards re-
gression for coronary revascularisation, mortality during
the entire follow-up period and time to further events.
For coronary revascularisation and time to further
events, we accounted for death as a competing risk, cen-
soring at the date of death. To evaluate coronary revas-
cularisation within 30 days, we also censored individuals
alive at 30 days at this time point. We included age at
MI and year of MI as continuous variables modelled as
fractional polynomials in order to allow for non-linear
relationships between these variables and the outcomes
[24], and the remaining covariates as categorical vari-
ables. For each outcome, model 1 included SMI, age at
MI, sex and year of MI, while model 2 additionally in-
cluded history of alcohol use disorder, deprivation,
urbanicity and health board. To investigate whether as-
sociations between SMI and each of the outcomes varied
by age at MI, sex and year of MI model 3 also included
two-way interaction terms between mental health condi-
tion and each of these variables. Based on model 3, we
used analysis of deviance to evaluate the statistical sig-
nificance of the interactions and plotted odds ratios (or
hazard ratios) by year of MI and sex for people with MI
at different ages. We also developed a Shiny app to dis-
play additional interactive plots of trends by year of MI
and age at MI (https://uiphsi-mdcvddm.shinyapps.io/mi-
outcomes-mmd/). Among those who survived more than
30 days, we fitted a fourth model for analyses of mortal-
ity and further events, adjusting for receipt of revascular-
isation within 30 days.
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In sensitivity analyses, we redefined major depression
based on psychiatric hospital admission records only and
identified coronary revascularisation within 90 days of
MI. We used R version 3.6.1 for all analyses [25].
Results
Cohort characteristics
We identified 243,091 people with a first-ever MI be-
tween 1991 and 2014. After exclusions, we included 235,
310 in our study cohort (see flow chart in Additional file
1: Fig. S1). Of these, 923 (0.4%), 642 (0.3%) and 6239
(2.7%) had a hospital admission record of schizophrenia,
bipolar disorder and major depression, respectively. The
prevalence of each SMI was higher in 2014 than in 1991
(0.6% versus 0.2% for schizophrenia, 0.4% versus 0.2%
for bipolar disorder and 3.9% versus 1.7% for depres-
sion), which partly reflects a longer look-back period for
hospital recording of SMI in people whose MI occurred
in later years of the study period. Comparison of SMI
prevalence using the minimum 10-year look-back period
for all MI patients still revealed an increased prevalence
of each SMI in later years, suggesting that improved
diagnosis of SMI over time and better recording of SMI
in general hospital admission records might also play a
role. Almost 60% of the cohort were male. There were
more men than women in the group with schizophrenia,
but more women among those with bipolar disorder and
major depression (Table 1). MI occurred at a younger
age in people with schizophrenia and bipolar disorder
(62 and 68 years, respectively) than those with no mental
health condition (69 years). Compared to those with no
mental illness, people with each psychiatric disorder
tended to be of lower socioeconomic status, more likely
to have an alcohol use disorder and more likely to have
diabetes, COPD and heart failure recorded in their MI
admission record. The median follow-up time was 5.3
years (interquartile range 0.4 to 11.6). Overall, 30-day
and 1-year mortality were 19.7% and 29.7%, respectively,
and 16.4% received coronary revascularisation within 30
days (Table 1, Additional file 1: Tables S5 and S6).
Absolute rates of mortality and coronary revascularisation
by time period
In general, absolute age-standardised sex-specific pro-
portions of 30-day and 1-year mortality were higher in
the groups with a SMI identified from hospital records
than in the comparison population with no such record
and declined between 1991 and 2014 in all groups
(Fig. 1). However, smaller numbers of people with
schizophrenia and bipolar disorder introduce a greater
degree of uncertainty in the pattern of change over time
for these conditions. Whilst the absolute proportion of
coronary revascularisation within 30 days increased over
time in all comparison groups, rates remained much
lower in people with each psychiatric disorder than in
the comparison group.
Relative effect of SMI on MI outcomes and coronary
revascularisation
After adjusting for age at MI, year of MI and sex, having
a prior hospitalisation record for each of schizophrenia,
bipolar disorder and major depression was associated
with statistically significant higher risks of mortality and
further events, but lower rates of coronary revascularisa-
tion. These associations attenuated slightly after add-
itional adjustment for alcohol use disorder, deprivation,
urbanicity and health board (Table 2; model 2). The
odds of 30-day mortality were higher in people with
schizophrenia (OR 1.95, 95% CI 1.64–2.30), bipolar dis-
order (OR 1.53, 95% CI 1.26–1.86) and depression (OR
1.31, 95% CI 1.23–1.40) compared to the group with no
hospital record of a mental health condition. There were
larger differences in 1-year and 5-year mortality
(Table 2). Among those who survived the first 30 days
post-MI, a prior history of each SMI was associated with
increased odds of over a third of further MI and further
vascular events (Table 2). All three disorders were asso-
ciated with a substantially reduced rate of coronary
revascularisation within 30 days, which was most marked
for schizophrenia (HR 0.57, 95% CI 0.48–0.67; Table 2).
Sensitivity analyses for each of the outcomes gave similar
results (Additional file 1: Table S7).
Interaction between SMI and year of MI, sex and age at
MI
From 1991 to 2014, there was no clear change in the
odds ratios for 30-day, 1-year and 5-year mortality
(Figs. 2 and 3, Additional file 1: Table S8 and Fig. S2).
However, survival analysis for the whole follow-up
period (which has more statistical power than logistic re-
gression) suggested that for MIs that occurred in later
years, there was a widening of the disparity between
people with a hospitalisation record of major depression
and those with no hospital record for any mental health
condition (Additional file 1: Table S8 and Fig. S3). For
MIs occurring at age 70 (approximately the mean age at
first MI), the hazard ratio for death during follow-up for
individuals with major depression versus those without a
mental health condition increased from 1.01 (95% CI
0.81–1.26) for MIs in 1991 to 1.43 (95% CI 1.29–1.58)
for MIs in 2014 in women and from 1.07 (95% CI 0.86–
1.34) to 1.52 (95% CI 1.37–1.69) in men. We observed a
similar relative percentage increase in the hazard ratios
for other ages. The results for people with schizophrenia
and bipolar disorder were uncertain, with wide confi-
dence intervals, due to smaller numbers of people in
these groups. There was no evidence of a change from
1991 to 2014 in the association between SMI and
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revascularisation (Fig. 4, Additional file 1: Table S8 and
Fig. S6). Again, results for people with schizophrenia
and bipolar disorder were uncertain.
There was no statistically significant interaction be-
tween SMI and sex for the mortality outcomes, but the
reduction in revascularisation among those with major
Table 1 Baseline characteristics and outcomes of patients with MI, by a history of mental health admission
No mental health







Median follow-up time (IQR), years 5.4 (0.4, 11.7) 4.3 (0.2, 8.9) 3.2 (0.1, 8.6) 3.2 (0.1, 8.0)
Sex, n (%)
Female 93,813 (41.2%) 369 (40.0%) 347 (54.0%) 3555 (57.0%)
Male 133,693 (58.8%) 554 (60.0%) 295 (46.0%) 2684 (43.0%)
Mean age at MI (SD), years 69.1 (13.2) 62.3 (13.5) 67.5 (12.7) 68.9 (13.8)
Year of MI admission, n (%)
1991–1995 60,050 (26.4%) 165 (17.9%) 121 (18.8%) 1020 (16.3%)
1996–2000 48,701 (21.4%) 168 (18.2%) 106 (16.5%) 1067 (17.1%)
2001–2005 44,426 (19.5%) 196 (21.2%) 161 (25.1%) 1278 (20.5%)
2006–2010 39,507 (17.4%) 184 (19.9%) 135 (21.0%) 1461 (23.4%)
2011–2014 34,822 (15.3%) 210 (22.8%) 119 (18.5%) 1413 (22.6%)
Deprivation quintile, n (%)
1 (most deprived) 50,898 (22.4%) 279 (30.2%) 156 (24.3%) 1609 (25.8%)
2 47,691 (21.0%) 195 (21.1%) 133 (20.7%) 1345 (21.6%)
3 45,792 (20.1%) 188 (20.4%) 106 (16.5%) 1213 (19.4%)
4 44,557 (19.6%) 163 (17.7%) 125 (19.5%) 1131 (18.1%)
5 (least deprived) 38,568 (17.0%) 98 (10.6%) 122 (19.0%) 941 (15.1%)
Urbanicity, n (%)
Large urban area 78,299 (34.4%) 365 (39.5%) 271 (42.2%) 2408 (38.6%)
Other urban area 80,536 (35.4%) 354 (38.4%) 203 (31.6%) 2064 (33.1%)
Accessible small town 20,597 (9.1%) 53 (5.7%) 49 (7.6%) 527 (8.4%)
Remote small town 9415 (4.1%) 28 (3.0%) 29 (4.5%) 291 (4.7%)
Accessible rural 23,960 (10.5%) 84 (9.1%) 56 (8.7%) 532 (8.5%)
Remote rural 14,699 (6.5%) 39 (4.2%) 34 (5.3%) 417 (6.7%)
History of alcohol use disorder, n (%) 5177 (2.3%) 138 (15.0%) 70 (10.9%) 915 (14.7%)
Diabetes recorded at MI admission, n (%) 22,449 (9.9%) 115 (12.5%) 74 (11.5%) 772 (12.4%)
COPD recorded at MI admission, n (%) 12,523 (5.5%) 77 (8.3%) 45 (7.0%) 659 (10.6%)
Heart failure at MI admission, n (%) 37,796 (16.6%) 171 (18.5%) 110 (17.1%) 1067 (17.1%)
30-day mortality, n (%) 44,580 (19.6%) 203 (22.0%) 154 (24.0%) 1443 (23.1%)
1-year mortality, n (%) 66,977 (29.4%) 309 (33.5%) 247 (38.5%) 2306 (37.0%)
Revascularisation within 30 days*
Any, n (%) 37,375 (16.4%) 137 (14.8%) 94 (14.6%) 1036 (16.6%)
CABG, n (%) 3175 (1.4%) 7 (0.8%) 8 (1.2%) 56 (0.9%)
PTCA, n (%) 8219 (3.6%) 30 (3.3%) 22 (3.4%) 193 (3.1%)
PCI, n (%) 26,450 (11.6%) 104 (11.3%) 65 (10.1%) 805 (12.9%)
5-year mortality†
N 219,161 868 611 5897
n (%) 100,560 (45.9%) 457 (52.6%) 350 (57.3%) 3388 (57.5%)
CABG coronary artery bypass graft, COPD chronic obstructive pulmonary disease, PCI percutaneous coronary intervention, PTCA percutaneous transluminal
coronary angioplasty
*Individuals may have received more than one type of revascularisation operation
†Based on the 225,730 individuals with their first MI between 1991 and 2013
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Fig. 1 Age-standardised rates of 30-day mortality, 1-year mortality and coronary revascularisation within 30 days following a myocardial infarction,
by previous hospitalisation with severe mental illness, 1991–2014. Shading represents 95% confidence intervals
Table 2 Effect estimates for MI outcomes in people with versus without a prior mental health admission
Outcome Number Model Schizophrenia Bipolar disorder Depression
30-day mortality, OR (95% CI) 235,310 Model 1 2.06 (1.74, 2.44) 1.58 (1.30, 1.91) 1.37 (1.29, 1.46)
Model 2 1.95 (1.64, 2.30) 1.53 (1.26, 1.86) 1.31 (1.23, 1.40)
1-year mortality, OR (95% CI) 235,310 Model 1 2.41 (2.07, 2.81) 1.99 (1.66, 2.37) 1.65 (1.55, 1.75)
Model 2 2.22 (1.91, 2.59) 1.90 (1.59, 2.27) 1.53 (1.45, 1.63)
5-year mortality, OR (95% CI) 226,537* Model 1 3.11 (2.67, 3.63) 2.28 (1.89, 2.75) 2.08 (1.96, 2.22)
Model 2 2.75 (2.35, 3.20) 2.15 (1.78, 2.59) 1.82 (1.71, 1.94)
Mortality during follow-up, HR (95% CI) 235,310 Model 1 1.97 (1.82, 2.12) 1.63 (1.50, 1.79) 1.44 (1.40, 1.49)
Model 2 1.82 (1.68, 1.96) 1.55 (1.42, 1.70) 1.35 (1.31, 1.39)
Time to further MI, HR (95% CI) 188,930† Model 1 1.50 (1.31, 1.72) 1.38 (1.17, 1.63) 1.45 (1.38, 1.53)
Model 2 1.42 (1.24, 1.63) 1.34 (1.13, 1.58) 1.38 (1.31, 1.45)
Time to further vascular event, HR (95% CI) 188,930† Model 1 1.55 (1.37, 1.75) 1.45 (1.25, 1.68) 1.48 (1.41, 1.55)
Model 2 1.46 (1.29, 1.65) 1.40 (1.20, 1.62) 1.40 (1.33, 1.46)
Revascularisation within 30 days, HR (95% CI) 235,310 Model 1 0.52 (0.44, 0.62) 0.66 (0.54, 0.80) 0.71 (0.67, 0.76)
Model 2 0.57 (0.48, 0.67) 0.69 (0.56, 0.85) 0.78 (0.73, 0.83)
Model 1 is adjusted for age at MI, sex and year of MI. Model 2 is adjusted for age at MI, sex, year of MI, history of alcohol use disorder, deprivation, urbanicity and
health board
HR hazard ratio, OR odds ratio
*Myocardial infarction admissions up to 2013 in order to ensure that all individuals have at least 5 years of follow-up
†Individuals who survived more than 30 days after MI
Fleetwood et al. BMC Medicine           (2021) 19:67 Page 6 of 13
depression was greater for women than for men (Fig. 4
and Additional file 1: Fig. S6). There was an interaction
between age at MI and SMI, for 30-day and 1-year mor-
tality, mortality over the whole follow-up period and
revascularisation (Additional file 1: Table S8, Shiny app).
Absolute differences in mortality outcomes between
those with and without SMI were generally greatest for
MIs occurring between 60 and 80 years of age and smal-
lest among younger ages.
Finally, among those surviving 30 days, adjusting for
receipt of coronary revascularisation had minimal impact
on the associations of SMI with mortality and further
events.
Discussion
For people with a MI, having a prior hospitalisation rec-
ord of schizophrenia, bipolar disorder or major depres-
sion was associated with increased risk of dying in the
Fig. 2 Sex-specific odds ratios and 95% confidence intervals for 30-day mortality following a myocardial infarction, among 70-year-olds,
comparing people with a prior hospital record for each SMI versus no prior record of any mental health condition, 1991–2014. Estimates were
obtained from a logistic regression model adjusting for age at MI, year of MI, sex, deprivation, urbanity, health board and history of an alcohol
use disorder, including interactions between SMI and each of age at MI, year of MI and sex. Shading represents 95% confidence intervals
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short- and long term and having a further MI or another
vascular event. People with a SMI were far less likely to
receive coronary revascularisation; among those with
pre-existing major depression, this effect was more
marked in women than men. SMI disparities in both
risks of death and receipt of revascularisation did not
improve over the period from 1991 to 2014.
Our study benefits from several strengths. It is one of
the largest to examine the effect of SMI on MI
outcomes, and coronary revascularisation treatment.
Our national cohort was representative of people admit-
ted to hospital with an MI. We included people with
bipolar disorder and major depression, who have previ-
ously been little studied in this context, as well as those
with schizophrenia. Including only people with a hos-
pital record of schizophrenia, bipolar disorder or depres-
sion identified individuals at the more severe end of the
mental illness spectrum. Scotland has a universal
Fig. 3 Sex-specific odds ratios and 95% confidence intervals for 1-year mortality following a myocardial infarction, among 70-year-olds,
comparing people with a prior hospital record for each SMI versus no prior record of any mental health condition, 1991–2014. Estimates were
obtained from a logistic regression model adjusting for age at MI, year of MI, sex, deprivation, urbanity, health board and history of an alcohol
use disorder, including interactions between SMI and each of age at MI, year of MI and sex. Shading represents 95% confidence intervals
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healthcare system, and so our findings are unbiased by
inequalities in access to care based on health insurance
provision. The long period of data collection facilitated
analysis of time trends in associations with mortality and
revascularisation, which have previously been little stud-
ied. Moreover, we also investigated interaction by age at
MI and sex.
Since we ascertained prior SMI from general and psy-
chiatric hospital admission data, our findings may not be
generalizable to people with a SMI for which they have
never been admitted to hospital. There may have been
selection bias in that people with less severe depression
may have been included in the depression group because
they were admitted to a general hospital for an unrelated
disease. Reassuringly, sensitivity analyses where we
defined depression based on psychiatric hospital admis-
sions only gave very similar effect estimates. Unfortu-
nately, we did not have information on the date of onset,
Fig. 4 Sex-specific hazard ratios and 95% confidence intervals for revascularisation within 30 days following a myocardial infarction, among 70-
year-olds, comparing people with a prior hospital record for each SMI versus no prior record of any mental health condition, 1991–2014.
Estimates were obtained from a Cox proportional hazards model adjusting for age at MI, year of MI, sex, deprivation, urbanity, health board and
history of an alcohol use disorder, including interactions between SMI and each of age at MI, year of MI and sex. Shading represents 95%
confidence intervals
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or clinical diagnosis, of SMI (which may have occurred
prior to the hospital admission record used to ascertain
the presence of SMI) and so could not investigate the ef-
fect of duration of mental illness on MI prognosis. The
lack of appropriate data meant that we were unable to
account for potential confounding by lifestyle factors
(other than alcohol use disorders), such as smoking, diet
or physical exercise, or key comorbidities prior to hos-
pital admission with MI. Interestingly, adjustment for
these in previous studies did not appear to influence the
effect of SMI on mortality and revascularisation [7, 9,
10, 12, 14]. The main focus of our study was on MI
prognosis in terms of death, irrespective of cause, occur-
ring at key clinical time points, and so comparison of
death from specific causes, including CVD, was beyond
the scope of this study. Similarly, whilst we explored
whether differences in receipt of timely revascularisation
partly explained observed disparities in outcomes, it was
beyond the remit of this study to investigate more
broadly the contribution of coronary revascularisation at
any time point to these disparities.
The prevalence of each SMI condition among people
hospitalised for MI in our study is highly consistent with
that reported in a previous study that used a similar
method of ascertaining SMI comorbidity [6]. The in-
creased risks of short-term mortality among people with
schizophrenia in our study are consistent with the find-
ings in most previous studies [6, 7, 9, 12, 14, 26–28].
One study reported no difference in 30-day mortality
between those with and without schizophrenia, but in-
cluded far fewer people with schizophrenia than in our
study [29]. The similarly increased risks of 30-day and 1-
year mortality among people with bipolar disorder in
our study are consistent with the findings from a
Swedish study [6]. However, our findings on short-term
mortality in those with both bipolar disorder and de-
pression are not in keeping with other studies, which re-
port either no difference in [7, 9, 12] or a reduced risk of
[10] mortality in the former groups. However, potential
limitations of these studies include reduced statistical
power due to smaller numbers of patients with bipolar
disorder [13] and reliance on MI admission records to
determine the history of SMI potentially leading to
under-ascertainment of history of bipolar disorder and
depression [7, 9, 10]. We are aware of just one other
study examining long-term prognosis after MI in the
context of SMI, which also found that schizophrenia was
associated with a marked increase in long-term mortality
[14]. Our finding of interaction by age, but not sex,
aligns with the findings from Bodén et al. [6]. The lack
of interaction by sex on in-hospital mortality among
those with major depression concurs with the post hoc
findings from Schulman-Marcus et al. [10], but not with
those from Mohammed et al., who reported a greater
effect of depression (but not schizophrenia or bipolar
disorder) on in-hospital MI mortality among men than
among women [7]. Comparison of our findings on the
risk of further events with previous studies is difficult,
since these have either included further events within a
composite outcome or analysed these as in-hospital
complications only.
The magnitude of the effect of schizophrenia on re-
ceipt of coronary revascularisation in our study is in
keeping with that reported in other studies similarly un-
selected for age [7, 9, 12, 27, 28]. Two previous studies
similarly reported lower revascularisation rates among
those with bipolar disorder [12] and depression [10]. As
observed in our study, women in general are less likely
than men to receive coronary revascularisation, with two
studies also reporting that this was more marked among
people with depression [7, 10]. The reasons for the latter
observation are unclear and worthy of further
investigation.
Despite advances in primary and secondary prevention
of MI and overall improvement in MI mortality over
time, our study reveals persistent SMI disparities in MI
prognosis and coronary revascularisation over time in
Scotland. A nationwide Danish study reported a widen-
ing of the gap in MI mortality between those with and
without schizophrenia during a similar period as in our
study [14]. Two US-based studies reported that the gap
in revascularisation rates between those with and with-
out these three psychiatric disorders persisted between
2002 and 2013 [9, 10]. Similarly, a recent Danish study
reported no change over time in the association between
schizophrenia and lower revascularisation rates among
people with acute coronary syndrome (encompassing
both MI and unstable angina) [30].
The reasons for poorer MI outcomes among people
with a SMI remain unclear. The excess risks of mortal-
ity in the short- and long term and of further events in
our study support a multifactorial explanation. Poorer
lifestyle and comorbidity profiles in people with SMI do
not appear to account for the increased mortality risk,
and neither does MI severity [7, 9, 10, 12, 14]. Differ-
ences in acute intervention strategies could reflect re-
duced patient advocacy and capacity for procedural
consent in those with psychiatric illness, physician con-
cerns about compliance with medication and regular
follow-up, and assumptions about lifestyle behaviour
change. People with schizophrenia may be less likely to
be offered investigation and treatment for MI and more
likely to decline investigation and treatment [31]. How-
ever, robust qualitative studies are needed to identify
patient- and physician-specific factors that may be con-
tributing to the sub-optimal care of these vulnerable
groups. Adjustment for receipt of coronary interven-
tions only slightly attenuated mortality estimates in our
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study and in others [6, 13, 28], and poorer outcomes
are still observed in those with psychiatric illness where
the study population includes only those receiving cor-
onary revascularisation [32].
Differences in the prescription of and adherence to
pharmacological and lifestyle approaches to secondary
prevention (critical to reducing MI mortality) could
partly explain the apparent poorer effect of coronary
revascularisation on outcomes and the increased risk of
further events in those with SMI. A recent novel study
comparing secondary prevention treatment reported
higher mortality among untreated patients with schizo-
phrenia compared to the treated general population, but
no difference in mortality among those treated with any
combination of triple therapy drugs [33]. Further study
of this and other aspects of the MI care pathway in rela-
tion to psychiatric illness status is needed. Time from
symptom onset to hospital arrival (onset-to-door) and
from arrival to revascularisation (door-to-balloon) have
been linked to 1-year mortality [34] and could differ by
mental illness status. Cardiac rehabilitation is associated
with reduced MI mortality, but multiple barriers, includ-
ing low referral rates of patients from low socioeco-
nomic groups and low participation due to psychological
well-being [35], place people with SMI at a disadvantage
in terms of accessing this. Finally, some antipsychotic
and anti-depressant drugs prolong the Q-T interval [36]
(an independent predictor of MI mortality [37]), and
polypharmacy may augment this risk [38].
Conclusions
We found sustained SMI disparities in MI intervention
and prognosis. There is an urgent need to understand
and tackle the reasons for these disparities. Meanwhile,
cardiologists and general practitioners/family physicians
should be acutely aware of the potential for under-
treatment of MI patients who have a pre-existing SMI
and ensure that clinical decision-making is not inappro-
priately influenced by these comorbidities. Improved
inter-specialty collaboration, particularly between cardi-
ologists and psychiatrists, and including effective com-
munication with primary care could help minimise
inequalities in clinical care and ultimately contribute to
improved clinical outcomes for people with SMI.
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